Compare STXS & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STXS | KRMD |
|---|---|---|
| Founded | 1990 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.0M | 195.7M |
| IPO Year | 2004 | 2019 |
| Metric | STXS | KRMD |
|---|---|---|
| Price | $1.84 | $4.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $4.00 | ★ $6.50 |
| AVG Volume (30 Days) | ★ 375.0K | 131.9K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 16.67 | ★ 53.85 |
| EPS | N/A | ★ N/A |
| Revenue | $29,346,617.00 | ★ $41,127,366.00 |
| Revenue This Year | $34.08 | $20.32 |
| Revenue Next Year | $35.18 | $17.38 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $1.56 | $1.87 |
| 52 Week High | $3.59 | $6.61 |
| Indicator | STXS | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 42.15 | 37.82 |
| Support Level | $1.74 | $4.08 |
| Resistance Level | $1.95 | $4.34 |
| Average True Range (ATR) | 0.09 | 0.17 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 35.09 | 27.03 |
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.